Addressing the Concerns of Collection Compliance During a Pandemic

The rise of a pandemic introduced unique challenges to sample collection and critical chain of custody logistics. Biomarker testing generates more data at all phases of drug development, requiring better analytics within and across trials. Without integrated data, important milestones may be missed, decisions may be delayed and insights may go unrecognized. However, integrating data creates challenges for reconciling the data. Having confidence in the data with robust extraction, load and transform (ELT) tools and the predictive system analytics to forecast, manage, monitor, and mitigate is the key to success. This presentation will review challenges of reconciling dispersed information, benefits of integrated analytics, and share examples of real-time sponsor use cases.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/videos/Addressing-the-Concerns-of-Collection-Compliance-During-a-Pandemic.png